Logo
job logo

Director, Global Medical Oncology, Emerging Assets

Bristol-Myers Squibb, Princeton

Save Job

Working with Us

Challenging. Meaningful. Life‑changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high‑achieving teams. Take your career farther than you thought possible.

Position Summary

Antibody Drug Conjugates are revolutionizing oncology. Here at BMS, we are excited to have a strategic alliance to co‑develop and co‑commercialize a potential first‑in‑class EGFRxHER3 bispecific ADC, iza‑bren, in the US and outside of China. The Global Medical Director for Iza‑bren will serve as the strategic and operational leader for the global medical strategy of the Iza‑bren asset, with a focus on certain key indications under the leadership of the Medical Product Lead (MPL). As the Iza‑bren program expands into multiple tumor types, in a rapidly evolving oncology landscape, this role is pivotal in shaping the medical vision, driving execution across the asset lifecycle, and ensuring alignment with broader Oncology portfolio objectives.

Key Responsibilities

  • Drive the development and execution of the global medical strategy for Iza‑bren, ensuring alignment with clinical development, commercial, and access teams.
  • Serve as an advisor and collaborator to the MPL to support the Global Product Team (GPT) and cross‑functional launch teams.
  • Translate clinical development insights into medical plans that support launch readiness and lifecycle management.
  • Engage with key external stakeholders including thought leaders, investigators, and advocacy groups to gather insights and foster scientific exchange.
  • Represent BMS at global oncology congresses and forums, elevating the visibility of Iza‑bren and its clinical value.
  • Partner with R&D to influence trial design, endpoints, and data generation strategies for Iza‑bren.
  • Collaborate with Commercial, Market Access, and HEOR to integrate medical perspectives into brand strategy and patient journey mapping.
  • Work closely with Medical Communications teams to ensure scientific alignment and impactful dissemination of data.
  • Lead the medical planning process for Iza‑bren, including budgeting, resource forecasting, and performance tracking.
  • Provide medical review and strategic input for content development, ensuring consistency with asset strategy.
  • Facilitate matrix meetings and ensure effective follow‑up on decisions, risks, and action items.
  • Identify opportunities for innovation in medical execution, including digital engagement and real‑world evidence generation.
  • Contribute to broader Oncology initiatives such as Project Converge and strategic planning across Thoracic and H&N tumors.
  • Support business development evaluations and alliance partnerships relevant to Iza‑bren.

Qualifications

  • Advanced scientific degree (MD, PhD, PharmD) with oncology specialization preferred.
  • Minimum 5–7 years of experience in medical affairs or clinical development within the biopharmaceutical industry.
  • Proven leadership in global medical strategy and cross‑functional team management.
  • understanding of oncology therapeutic landscape, particularly thoracic cancers.
  • Excellent communication, stakeholder engagement, and strategic planning skills.

Compensation Overview

Princeton – NJ – US: $207,490 – $251,433. The starting compensation range is for a full‑time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. Final, individual compensation will be decided based on demonstrated experience.

Uniquely Interesting Work, Life‑Changing Careers

With a single vision as inspiring as “Transforming patients’ lives through science™”, every BMS employee plays an integral role in work that goes far beyond ordinary. Each of us is empowered to apply our individual talents and unique perspectives in a supportive culture, promoting global participation in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

On‑site Protocol

BMS has an occupancy structure that determines where an employee is required to conduct their work: site‑essential, site‑by‑design, field‑based and remote‑by‑design. Site‑essential roles require 100% of shifts onsite at the assigned facility. Site‑by‑design roles may be eligible for a hybrid model with at least 50% onsite. For field‑based and remote‑by‑design roles, the ability to travel to customers, patients or business partners and attend meetings on behalf of BMS as directed is an essential function.

Equal Employment Opportunity

BMS is dedicated to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace accommodations/adjustments, and ongoing support in their roles. Applicants can request a reasonable workplace accommodation/adjustment prior to accepting a job offer.

#J-18808-Ljbffr